课题基金 / 基金详情

Examining the Role of IRF8 in Tumor-Associated Macrophage Differentiation and Function

Examining the Role of IRF8 in Tumor-Associated Macrophage Differentiation and Function
检查 IRF8 在肿瘤相关巨噬细胞分化和功能中的作用
批准号:
9327355
负责人:
Briana Glyn Nixon
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-01 至 2020-02-29

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 肿瘤相关巨噬细胞(TAM)通常是在固体中发现的主要免疫细胞类型 人类肿瘤,虽然它们的存在与疾病预后不良相关,但它仍然是 已确定是什么触发并控制了它们的差异化。使用自发性的小鼠模型 乳腺癌与人类疾病密切相关,我们最近证明了TAMS 来源于单核细胞,它们的分化依赖于Notch信号,在没有它们的情况下, 肿瘤生长缓慢,肿瘤中的T细胞表达更多的效应分子和更少的分子 疲劳标记物,提示TAMS的免疫抑制作用。我提议的工作旨在 进一步探讨TAMs在肿瘤微环境中的分化程序和功能。我的 初步研究结果表明,TAMs特异性地表达高水平的转录因子 干扰素调节因子8(IRF8),并且在缺少IRF8的情况下,的分化被阻断。IRF8 已知是其他髓系细胞群体的关键谱系决定因素,并可介导 与抗原提呈相关的基因表达,从而影响T细胞反应。在这 建议,我的目的是用小鼠研究IRF8是如何介导分化和功能的 遗传学和疾病的小鼠模型。我将确定是什么外部线索驱动了IRF8表达式 以及IRF8使用全基因组染色质控制TAMS中的哪些遗传程序 免疫沉淀测序(CHIP-SEQ)和RNA测序。通过功能丧失研究 而在体外细胞培养实验中,我的工作将直接测量IRF8介导的的潜能 肿瘤微环境中T细胞和其他免疫细胞的免疫抑制活性。这个 概述的提案,使用明确的方法,将产生结论性的、有意义的数据,并将 拓宽了我们对的作用和身份的认识。我的发现可能会为 癌症免疫疗法操纵TAMs,增强内源性抗肿瘤反应和 为抗击癌症提供关键的新工具。
英文摘要
PROJECT SUMMARY/ABSTRACT Tumor-associated macrophages (TAMs) are often the dominant immune cell type found in solid human tumors, and while their presence is correlated with poor disease prognosis, it remains to be determined what triggers and controls their differentiation. Using a murine model of spontaneous breast cancer that closely recapitulates human disease, we have recently demonstrated that TAMs are derived from monocytes, their differentiation relies on Notch signaling, and in their absence, tumor growth is slowed and T cells in the tumor express more effector molecules and fewer exhaustion markers, suggesting an immunosuppressive role for TAMs. My proposed work aims to further explore the differentiation program and function of TAMs in the tumor microenvironment. My preliminary findings demonstrate that TAMs specifically express high levels of the transcription factor interferon regulatory factor 8 (IRF8), and in the absence of IRF8, TAM differentiation is blocked. IRF8 is known to be a key lineage-determining factor for other myeloid cell populations and can mediate expression of genes related to antigen-presentation, thus influencing T cell responses. In this proposal, I aim to characterize how IRF8 mediates TAM differentiation and function using mouse genetics and mouse models of disease. I will determine what external cues drive IRF8 expression and what genetic programs IRF8 controls in TAMs using genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) and RNA-sequencing. Through loss-of-function studies and ex vivo cell culture assays, my work will directly measure the potential IRF8-mediated TAM immunosuppressive activities on T cells and other immune cells in the tumor microenvironment. The outlined proposal, using definitive approaches, will generate conclusive, meaningful data and will broaden our understanding of TAM function and identity. My findings may uncover novel avenues for cancer immunotherapies to manipulate TAMs, boosting endogenous anti-tumor responses and providing critical new tools in the fight against cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金